Activities

Lipoprotein(a), or Lp(a), has emerged as a genetically determined, independent, and causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve stenosis. Despite its established clinical relevance, Lp(a) remains underrecognized and undertested in routine practice. This Advances in™...

Join leading optometrists and ophthalmologists for two days of high-impact education, real-world clinical insights, and meaningful collaboration at EyeCon 2026, taking place September 26–27 at the Margaritaville Hollywood Beach Resort in Hollywood, Florida. Designed for today’s eye care professionals, EyeCon...

Adenosine deaminase–deficient severe combined immunodeficiency (ADA-SCID) is a rare, life-threatening inborn error of the immune system characterized by profound T-, B-, and NK-cell dysfunction and multiorgan complications beginning in early infancy. Integration of newborn screening using T-cell receptor excision circles,...

Patients with diabetic retinopathy (DR) or diabetic macular edema (DME) tend to have a host of comorbidities and a considerable burden of required treatments and medical appointments. Recent additions to treatment options for DR and DME provide opportunities to reduce...

Nearly half the population older than 60 years has more than 1.0 diopter of keratometric astigmatism. With the emergence of more advanced intraocular lenses (IOLs) and surgical technologies, corneal astigmatism management has become an important treatment goal in modern cataract...

Recent advances in the treatment of presbyopia have focused on pharmacological agents as a novel therapeutic strategy that offers noninvasive, reversible options capable of enhancing depth of focus without altering the natural lens structure. As new and emerging pharmacological therapies...

Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis globally and an important cause of chronic kidney disease and kidney failure in young adults. As understanding of its complex autoimmune and inflammatory mechanisms deepens, new opportunities are emerging to...

Much progress has been made in managing and treating atopic dermatitis (AD) within the past few years. This 3-day conference will focus exclusively on AD and the complex information that has accrued around proper diagnosis, treatment, and management. Since its...

Macular telangiectasia type 2 (MacTel) is a rare, progressive retinal disease characterized by neurodegenerative changes, localized retinal degeneration, and alterations in the retinal vasculature. It usually presents bilaterally and leads to gradual central vision loss, and its early signs and...

Cardiometabolic disorders are a significant source of morbidity and mortality in psoriatic disease. The presence of traditional cardiovascular (CV) risk factors, such as hypercholesterolemia, metabolic syndrome, and obesity, contributes to the elevated risk of CV disease in patients with psoriasis....